ʱ¼ä:2016-12-1À´Ô´:±¾Õ¾Ô­´´×÷Õß:ØýÃû

ÒÉ»ó

ÌÖÂÛѪÁ÷¸ÐȾ¡¢ÑªÒºÎÛȾ¡£ÓÐÕã½­ÀöË®ÈÎÀÏʦÎʼ°£ºÐÂÉú¶ùÄý¹ÌøÒõÐÔÆÏÌÑÇò¾úCNSÊÇ·ñÎÛȾΪÖ÷£¿±ÊÕßãȻ£¡

ÖÚËùÖÜÖª£¬Ò½Ôº»ñµÃÐÔѪÁ÷¸ÐȾÖУ¬CNS£¨Ö÷ÒªÊÇ±íÆ¤ÆÏÌÑÇò¾úSEP£©ÊÇ×î³£¼ûÖ²¡¾ú£¬Ò²ÊÇ×î³£¼ûÎÛȾ¾ú¡£ÑªÅàÑø·ÖÀëCNS£¬¹ú¼ÊÉϱ¨µÀÖ»ÓÐ10%Ϊ¸ÐȾ£¬¹úÄÚ±ê×¼¿íËÉһЩ£¬Ò²½öÓÐ30%ÊǸÐȾ¡£ÓàÔòÎÛȾ£¡ÐÂÉú¶ùÈçºÎ£¿

²éÎÄÏ×½â»óPart1

²éÅ·ÖÞ¡¶¶ùͯ¸ÐȾÐÔ¼²²¡À¶Æ¤Êé¡·µÚ30ÕÂÐÂÉú¶ù¸ÐȾÖУ¬²¡Ô­Èý·Ö£º

1.¹¬ÄÚ¸ÐȾ£º²¡¶¾£¨·çÕ¶¾¡¢CMV¡¢Ï¸Ð¡²¡¶¾B19¡¢HBV¡¢HIV¡¢VZV£©¡¢Ï¸¾ú£¨µ¥À÷¶¾¡¢½áºË£©¡¢¹­Ðγæ

2.²úʱ£ºÏ¸¾ú£¨GBS¡¢³¦¿Æ¡¢¼Ùµ¥°û¾ú¡¢Áܾú¡¢ÒÂÔ­Ì壩ΪÖ÷£¬ÉÙÊýÊDz¡¶¾£¨HIV¡¢HSV¡¢HBV£©

3.²úºó¸ÐȾ²¡Ô­£ºCNS¡¢½ðÆÏ¡¢·ÎË«¡¢³¦¿Æ¡¢¼Ùµ¥°û¾ú¡¢³¦Çò¾ú¡¢GBS¡£²¡¶¾ÉÙ£¬µ«CMV¡¢HSV¡¢Á÷¸Ð²¡¶¾¡¢¸±Á÷¸Ð²¡¶¾¡¢ÏÙ²¡¶¾¡¢ÂÖ×´²¡¶¾¿ÆÒýÆð±©·¢¡£Õæ¾úÖ÷ÒªÊǰ×Ä¼ûÓÚNICU¡£

¿É¼ûCNSÊDzúºó¸ÐȾ²¡Ô­Ö®Ò»¡£

²éÎÄÏ×½â»óPart2

PPPID3chapter12רÂÛSIRSºÍŧ¶¾Ö¢sepsis¡£ÄÚÈÝÌáµ½£ºÐÂÉú¶ùÆÚ£¬Ö÷ÒªµÄϸ¾úÐÔ²¡Ô­°üÀ¨GBS¡¢³¦¿Æ¡£ÉÙ¼û°üÀ¨³¦Çò¾ú¡¢µ¥Àî¡¢Á÷¸ÐºÍ·ÎË«¡£Ëæ×Åҽѧ½ø²½£¬VLBWI£¨¼«µÍ³öÉúÌåÖØÓ¤¶ù£©ÒÔÒ½Ôº»ñµÃÐÔ¸ÐȾΪÖ÷£¬ÓÉѪ¹ÜÄÚ²å¹ÜµÈµ¼Ö£¬²¡Ô­°üÀ¨CNS¡¢½ðÆÏ¡¢ÒõÐԸ˾úºÍÄîÖé¾ú¡£²¡¶¾Ò²µ¼ÖÂÐÂÉú¶ùŧ¶¾Ö¢£¬ÁÙ´²±íÏÖÓëϸ¾úÏàËÆ£¬°üÀ¨HSV¡¢³¦²¡¶¾¡¢RSV¡¢Á÷¸Ð²¡¶¾¡£

±ÊÕß°´£ºÐÂÉú¶ùÐèÒª½øÒ»²½Ï¸·Ö¡£VLBWIÖУ¬CNSÊÇÖØÒª²¡Ô­¡£ÓÉ´Ë¿ÉÖª£¬CNSÊDz¡Ô­£¬ÓÈÆäÊÇVLBWI»òÃâÒßµÍÏÂʱµÄ²¡Ô­£¬ÒÑÊǶ¨ÂÛ¡£ÄÇʵÑéÊÒ·ÖÀëÖ꣬¾¿¾¹ÓжàÉÙÊÇÖ²¡ÄØ£¿»»¾ä»°Ëµ£¬CNS·ÖÀëÖêµÄÑôÐÔÔ¤²âÖµÊǶàÉÙ£¿

²éÎÄÏ×½â»óPart3

ÏÂÃæÎÄ×ÖÖÐ

1ÑôÐÔÂÊ£ºÓзÖÀëÖêÉú³¤µÄ±ê±¾Õ¼È«²¿±ê±¾µÄ±ÈÂÊ¡£ÆäÖмÈÓиÐȾ£¬Ò²ÓÐÎÛȾ¡£

2ÎÛȾÂÊ£ºÎÛȾ·ÖÀëÖê±ê±¾Õ¼È«²¿±ê±¾µÄ±ÈÂÊ¡£

3ÎÛȾ±ÈÀý£ºÄ³¾úÖÖ·ÖÀëÖêÖУ¬ÎÛȾռȫ²¿·ÖÀëÖêµÄ¹¹³É±È¡£

PubmedÖУ¬±ÊÕßÓÃ(neonatalORneonatesORneonateORnewborn)and(bacteremiaORbacteraemiaORsepsisORsepticemiaORsepticaemia)and(microbiologyORmicrobiologicalORpathogensORpathogenORbacteriologyORbacteriological)¼ìË÷£¬ÌâÄ¿ÖгöÏÖÕß77¸ö¡£Ã»ÓÐÎÛȾ±ÈÀýÊý¾Ý¡£

ÓÃ(neonatalORneonatesORneonateORnewborn)and(bacteremiaORbacteraemiaORsepsisORsepticemiaORsepticaemiaor¡°bloodstreaminfection¡±or¡°bloodculture¡±or¡°bloodisolates¡±)and(contaminationorcontaminated)and(Staphylococciorstaphylococcus)¼ìË÷£¬ÌâÄ¿»òÕªÒªÖгöÏÖ65¸ö¡£ÏÂÃæÎÄÕÂÉæ¼°·ÖÀëÖêÎÛȾ±ÈÀý£º

¢Ù¼ÓÄÉÑо¿£¨AnnClinMicrobiolAntimicrob.Aug18;15(1):49.£©Ìáµ½ÎÛȾ±ÈÀý¡£ÎÞÈ«ÎÄ¡£ÓÐÑôÐÔÂÊÅÅÃû£¬Ó¤¶ù¡¢ÀÏÄê¡¢¶ùͯ¡¢³ÉÈË·Ö±ðÊÇ20.9%¡¢13.3%¡¢8.9%¡¢7.2%¡£

¢ÚÄÏ·ÇÑо¿£¨BMCPediatr.Apr2;15:33.£©Ìáµ½Õû¸ö¶ù¿ÆÎÛȾÂÊÊÇ6.6%¡£ÎÞÈ«ÎÄ¡£

¢ÛÈû¶ûάÑÇÑо¿£¨MalawiMedJ.Mar;27(1):20-4.£©Ìáµ½£¬CNSÊÇ×î³£¼ûÎÛȾ¡£ÎÞÈ«ÎÄ¡£

¢Ü±£¼ÓÀûÑÇÑо¿£¨AkushGinekol(Sofiia).;53(2):25-30.£©Ìáµ½£¬ÐÂÉú¶ùѪÅàÑø24¸öCNSÖÐ11ÎÛȾ£¬ÎÛȾ±ÈÀýÊÇ45.8%¡£CNSÒ²ÊÇ×î³£¼ûµÄ²¡Ô­¡£

¢ÝÎ÷°àÑÀÑо¿£¨EnfermInfeccMicrobiolClin.Jun-Jul;31(6):-9.£©Ìáµ½£¬ÐÂÉú¶ù¡¢Ó¤¶ùѪÅàÑøÎÛȾÂÊ16.7%£¬×î³£¼ûÎÛȾ¾úÊÇCNSºÍ²ÝÂÌÉ«Á´Çò¾ú¡£ÎÞÈ«ÎÄ¡£

¢Þ°Ä´óÀûÑÇÑо¿£¨BMJOpen.May15;2(3).pii:e.£©Ìáµ½Ì×ѪÅàÑø£¬¸ö·ÖÀëÖ꣬Èý·ÖÖ®Ò»ÊǸÐȾ£¬Èý·ÖÖ®¶þÊÇÎÛȾ¡£¿ÉÖª×ÜÌåÎÛȾ±ÈÀý³¬¹ý66%¡£ÎÞÈ«ÎÄ¡£

±ÊÕß°´:Èç¹û¶¼Êǵ¥¸ö·ÖÀëÖ꣬ÔòÑôÐÔÂʸߴï49.2%£¬¹À¼ÆÓмÆËã¿Ú¾¶ÎÊÌâ¡£×ÜÌåÎÛȾ±ÈÀý´ï66%£¬ÒòΪCNSÊÇ×î³£¼ûÎÛȾ¾ú£¬ËùÒÔCNSÎÛȾ±ÈÀýÓ¦¸Ã¸ßÓÚ66%¡£

¢ßÒÁÀÊÑо¿£¨MedPrincPract.;20(2):-6.£©ÓÐÈ«ÎÄ¡£39¸ö±íƤÆÏÌÑÇò¾ú£¬¶¼ÊÇÎÛȾ¡£ÎÛȾ±ÈÀý%¡£Ò»¹²49¸öÎÛȾÖ꣬±íƤÆÏÌÑÇò¾úÕ¼79.6%¡£

±ÊÕß°´:ÕâÒ»ÌõҲ˵Ã÷£¬×î³£¼ûÎÛȾ¾úÊÇCNS¡£

¢àÖйų́ÍåÑо¿£¨JMicrobiolImmunolInfect.Mar;36(1):51-5.£©£ºÖØÖ¢¶ùͯ67¸öѪҺ·ÖÀëÖ꣬30¸öÎÛȾ¡£ÎÛȾ±ÈÀý44.8%¡£

¢áÆÏÌÑÑÀÑо¿£¨JPediatr(RioJ).Jul-Aug;78(4):-88.£©£ºÐÂÉú¶ùѪҺ·ÖÀëÖ꣬57(48.7%)ÊÇÎÛȾ¡£

¢âÎ÷°àÑÀÑо¿£¨AnEspPediatr.Aug;53(2):-47.£©£ºÐÂÉú¶ù²å¹Üµ¼ÖÂŧ¶¾Ö¢£¬×î³£¼û·ÖÀëÖêÊÇCNS£¬ÓÈÆäÊÇSEP£¬Õ¼µ½ÎÛȾµÄ71.1%£¬²å¹ÜÏà¹ØÅ§¶¾Ö¢²¡Ô­µÄ50%¡£

?µÂ¹úÎÄÕ£¨PLoSOne.Jul29;11(7):e.£©Ìáµ½£¬9¸öѪÅàÑøÑôÐÔ¶øPCRÒõÐÔµÄCNSÖУ¬1¸öÊÇÎÛȾ¡£

±ÊÕß°´£ºÍ¨¹ýÉÏÃæÊý¾Ý¿ÉÖª£¬CNSÊÇÐÂÉú¶ùѪÅàÑø×î³£¼ûÎÛȾ¾ú¡£²¿·Ö»¼ÕßÊÇ×î³£¼ûÖ²¡¾ú¡£CNS·ÖÀëÖêÎÛȾ±ÈÀýÔÚ44.8%¡¢45.8%¡¢48.7%¡¢%£¬Õâ4¸öÜöÝÍÆ½¾ùÊÇ/=55.5%¡£ÁíÓÐÑо¿Ìáʾ66%¡£Êý×Ö²î±ð±È½Ï´óÊÇÕý³£µÄ£¬ÒòΪÁÙ´²×´Ì¬Ææ¶à¡¢Õï¶Ï±ê×¼ÆçÒì¡¢Èëѡʱ¼äÊýÁ¿¸÷²»Í¬¡¢ÑªÅàÑø¼¼ÊõÒ²¸÷ÓÐÌØµã¡£

²éÎÄÏ×½â»óPart4

ÆäËûÖØÒªÐÅÏ¢£º

1.ÐÂÉú¶ùCNS¸ÐȾ×ÛÊö£ºÃÀ¹ú£¨SeminPediatrInfectDis.Jul;17(3):-7.£©¡¢µÂ¹ú£¨Kinderkrankenschwester.Jan;35(1):24-7.£©

2.Ó¢¹úÎÄÕ£¨ArchDisChildFetalNeonatalEd.Jan;94(1):F8-12.£©¸ø³öÁËÐÂÉú¶ùѪÁ÷¸ÐȾ¼à²â¶¨Òå¡£¡Ý3¸öÁÙ´²ÌåÕ÷ÊÇÑôÐÔѪÅàÑø×î¼ÑÔ¤²âÖ¸±ê£¬ÌØÒìÐÔ76.2%£¬¶ÔѪÅàÑøÑôÐÔ¡¢CNSºÍÈ·¶¨²¡Ô­£¬Ãô¸ÐÐÔ·Ö±ðÊÇ61.5%¡¢46.9%¡¢78.2%¡£

±ÊÕß°´£ºÕâÊÇÊÊÓ¦Õ÷Ñо¿¡£ºÍ³ÉÈËÒ»Ñù£¬ÊÊÓ¦Õ÷²»È·¶¨¡£

3.Ó¡¶È´óÐÍÑо¿£¨LancetGlobHealth.Oct;4(10):e-60.£©£ºÄê7ÔÂ18ÈÕµ½Äê1ÔÂ28ÈÕ£¬»îÓ¤ÖÐÈë×顣ŧ¶¾Ö¢ÕûÌå·¢ÉúÂÊ14.3%(95%CI13.8-14.9)£¬ÅàÑøÑôÐÔŧ¶¾Ö¢6.2%(5.8-6.6)¡£ÔçÆÚŧ¶¾Ö¢£¨Éúºó72hrÄÚ£©£¨µÄ83%£©¡£Èý·ÖÖ®¶þ(/5=64%)ÊǸïÀ¼ÒõÐÔ¾ú£¬²»¶¯22%¡¢¿ËÀײ®17%¡¢´ó³¦°£Ï£¾ú14%¡£ÔçÆÚºÍÍíÆÚŧ¶¾Ö¢²¡Ô­¹¹³ÉÎÞÇø±ð¡£¶àÖØÄÍÒ©±ÈÀý¸ß£¬²»¶¯82%¡¢¿ËÀײ®54%¡¢´ó³¦°£Ï£¾ú38%¡£MRCNS±ÈÀý61%(85/)¡¢MRSA±ÈÀý38%(43/)¡£ËÄ·ÖÖ®Ò»ËÀÍö¹éÒòÓÚŧ¶¾Ö¢¡£ÅàÑøÒõÐÔŧ¶¾Ö¢¡¢ÅàÑøÑôÐÔ¶àÄ;úŧ¶¾Ö¢¡¢ÅàÑøÑôÐԷǶàÄ;úŧ¶¾Ö¢µÄÈËȺËÀÍö·çÏÕ·Ö±ðÊÇ8.6%¡¢15.7%¡¢12.0%¡£

4.Öйų́ÍåÎÄÕ£¨AnnTropPaediatr.Dec;26(4):-8.£©Ìáµ½£¬¶ÔCNS¸ÐȾ£¬µ¥Ì×ѪÅàÑøÑôÐÔÓëË«Ì×ѪÅàÑøÑôÐԱȽϣ¬ÈË¿ÚÑ§ÌØÕ÷¡¢·çÏÕÒòËØ¡¢ÁÙ´²±íÏÖ¡¢ÊµÑéÊÒÒì³£¡¢´¦ÖúÍÔ¤ºóÎÞÇø±ð¡£

5.CNSÉúÎïĤ£¬Óë¸ÐȾ£¨JClinMicrobiol.Feb;40(2):-8.£©»ò³ÖÐøÐÔ¸ÐȾ£¨ClinMicrobiolInfect.Nov;17(11):-90.£©Óйء£

6.ÃÀ¹úÎÄÕ£¨Neonatology.;94(2):-31.£©£º²»×ãÔÂÐÂÉú¶ùŧ¶¾Ö¢Ç°Æ¤·ôÅàÑøÔ¤²â²¡Ô­¡£¸öѪÅàÑø£¬Å§¶¾Ö¢Ç°13ÌìÄÚÆ¤·ôÅàÑø¡£ÕûÌåÃô¸ÐÐÔ¡¢ÌØÒìÐÔ¡¢ÑôÐÔÔ¤²âÖµPPVÊÇ16%¡¢38%¡¢5%¡£·Î¿Ë±©·¢ÆÚ¼äÑôÐÔÔ¤²âÖµÊÇ9%¡£3¸ö²ÉÑùλµãÖи¹¹É¹µPPV×î¸ßΪ6%¡£²»¶¯¡¢·Î¿ËÌØÒìÐÔPPVÊÇ28%¡¢23%¡£ÄîÖé¾ú¡¢³¦¸Ë¾úÊô¡¢É³ÃžúÊôÔò2%¡£

±ÊÕß°´£ºÕâ˵Ã÷¼à²âÐÔÅàÑø¼ÛÖµ²»´ó

7.ѪÅàÑøÒòΪÑôÐÔÂʵͣ¬ºÄʱ³¤£¬ÄÑÒÔ¼ì³öµÍŨ¶È²¡Ô­£¬ËùÒÔËäÈ»ÊǾúѪ֢Õï¶Ï½ð±ê×¼£¬µ«·Ö×Ó·½·¨ÊÇδÀ´±ØÈ»¡£²Î¼ûÃÀ¹ú×ÛÊö£¨ExpertRevAntiInfectTher.Sep;8(9):-48.£©¡£

±ÊÕßС½á

×ÛÉÏ£¬±ÊÕßÈÏΪ£¬CNSÔÚÐÂÉú¶ùѪÅàÑøÖÐ

1.ÊÇ×î³£¼ûÎÛȾ¾ú¡£

2.²¿·Ö»¼ÕßÊÇ×î³£¼ûÖ²¡¾ú£¬±ÈÈçVLBWI»òÃâÒßµÍÏ¡£

3.CNS·ÖÀëÖêÎÛȾ±ÈÀýÔÚ°ëÊý£¬ÉõÖÁ³¬¹ýÈý·ÖÖ®¶þ¡£ËùÒÔÑôÐÔÔ¤²âÖµµÍÓÚ50%£¬ÉõÖÁ²»µ½Èý·ÖÖ®Ò»¡£

4.È·Èϲ¡Ô­ºÍÎÛȾ£ºÒÀÀµÓÚ·çÏÕÒòËØ¡¢ÁÙ´²±íÏÖ¡¢ÊµÑéÊÒÒì³£¡¢Ó°ÏñѧµÈ¼ì²é¡£ÕâÒ»Ìõ±ÊÕßûÓÐÕ¹¿ª¡£

5.ÓгÖÐøÐÔ¸ÐȾ£¬×¢Òâ







































北京最好的白癜风医院是那个
白癜风预�

×ªÔØÇë×¢Ã÷Ô­ÎÄÍøÖ·£ºhttp://www.alilego.net/xsezl/29178.html

------·Ö¸ôÏß----------------------------